麻醉和癌症复发:一个叙事审查
1Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Anesthesia and pain medicine
|May 10, 2024
概括
麻醉剂可能会影响癌症复发和转移. 本综述探讨了麻醉选择如何影响癌症手术结果和手术后患者存活率.
科学领域:
- 在瘤学瘤学.
- 麻醉学 麻醉学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症是全球主要的健康问题,由于人口老龄化,癌症发病率越来越高.
- 手术切除是许多固体瘤的首要治疗方法,约80%的癌症患者参与了手术.
- 一般麻醉剂可以影响免疫反应和癌细胞行为,可能会影响外科手术之外的结果.
研究的目的:
- 审查有关麻醉剂对癌症手术结果的影响的当前文献.
- 探索麻醉可能影响癌症复发和转移的机制.
- 为了确定麻醉选择是否会影响癌症患者的长期存活率.
主要方法:
- 对麻醉和癌症结果现有的研究进行系统审查.
- 对研究麻醉剂对细胞因子释放,转录因子和瘤基因的影响的分析.
- 评估证据,将术后药物与癌症复发和转移联系起来.
主要成果:
- 麻醉剂可以调节宿主免疫力和癌细胞存活/迁移.
- 麻醉对癌症复发和转移的影响尚未完全理解.
- 术后的药物选择可能会影响癌症手术的结果.
结论:
- 在癌症手术中,麻醉和外科手术期间药物的选择需要仔细考虑.
- 需要进一步的研究来阐明麻醉与癌症进展之间的确切关系.
- 优化麻醉管理可能会改善癌症患者的长期生存率.
更多相关视频
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
General Anesthesia: Overview
212
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
212
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
231
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
231
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
197
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
197


